BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15349907)

  • 1. Reduced expression of cell cycle regulator p18(INK4C) in human hepatocellular carcinoma.
    Morishita A; Masaki T; Yoshiji H; Nakai S; Ogi T; Miyauchi Y; Yoshida S; Funaki T; Uchida N; Kita Y; Funakoshi F; Usuki H; Okada S; Izuishi K; Watanabe S; Kurokohchi K; Kuriyama S
    Hepatology; 2004 Sep; 40(3):677-86. PubMed ID: 15349907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
    Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
    Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent loss of p19INK4D expression in hepatocellular carcinoma: relationship to tumor differentiation and patient survival.
    Morishita A; Gong J; Deguchi A; Tani J; Miyoshi H; Yoshida H; Himoto T; Yoneyama H; Mori H; Kato K; Kurokohchi K; Deguchi K; Izuishi K; Suzuki Y; Kushida Y; Haba R; Iwama H; Watanabe S; D'Armiento J; Masaki T
    Oncol Rep; 2011 Dec; 26(6):1363-8. PubMed ID: 21901251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of p16 contributes to p27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma.
    Matsuda Y; Ichida T; Genda T; Yamagiwa S; Aoyagi Y; Asakura H
    Clin Cancer Res; 2003 Aug; 9(9):3389-96. PubMed ID: 12960127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6.
    Noh SJ; Li Y; Xiong Y; Guan KL
    Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
    Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G
    Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity.
    Sotillo R; Renner O; Dubus P; Ruiz-Cabello J; Martín-Caballero J; Barbacid M; Carnero A; Malumbres M
    Cancer Res; 2005 May; 65(9):3846-52. PubMed ID: 15867383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
    Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
    Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines.
    Timmermann S; Hinds PW; Münger K
    Cell Growth Differ; 1997 Apr; 8(4):361-70. PubMed ID: 9101082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic evidence for functional dependency of p18Ink4c on Cdk4.
    Pei XH; Bai F; Tsutsui T; Kiyokawa H; Xiong Y
    Mol Cell Biol; 2004 Aug; 24(15):6653-64. PubMed ID: 15254233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressor INK4: determination of the solution structure of p18INK4C and demonstration of the functional significance of loops in p18INK4C and p16INK4A.
    Li J; Byeon IJ; Ericson K; Poi MJ; O'Maille P; Selby T; Tsai MD
    Biochemistry; 1999 Mar; 38(10):2930-40. PubMed ID: 10074345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of G1 phase-related cell cycle molecules in naturally developing hepatocellular carcinoma of Long-Evans Cinnamon rats.
    Kita Y; Masaki T; Funakoshi F; Yoshida S; Tanaka M; Kurokohchi K; Uchida N; Watanabe S; Matsumoto K; Kuriyama S
    Int J Oncol; 2004 May; 24(5):1205-11. PubMed ID: 15067343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma.
    Fiorentino M; Altimari A; D'Errico A; Cukor B; Barozzi C; Loda M; Grigioni WF
    Clin Cancer Res; 2000 Oct; 6(10):3966-72. PubMed ID: 11051245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development.
    Zindy F; Soares H; Herzog KH; Morgan J; Sherr CJ; Roussel MF
    Cell Growth Differ; 1997 Nov; 8(11):1139-50. PubMed ID: 9372237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis.
    Masaki T; Shiratori Y; Rengifo W; Igarashi K; Yamagata M; Kurokohchi K; Uchida N; Miyauchi Y; Yoshiji H; Watanabe S; Omata M; Kuriyama S
    Hepatology; 2003 Mar; 37(3):534-43. PubMed ID: 12601350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation.
    Franklin DS; Xiong Y
    Mol Biol Cell; 1996 Oct; 7(10):1587-99. PubMed ID: 8898364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.
    Easton J; Wei T; Lahti JM; Kidd VJ
    Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.